Leukoreduction
Transfusion • Category : Leukoreduction

LEUCOFLEX In-line Red Blood Cells leukoreduction filters

The use of leukoreduction is a major step to improve transfusion safety thanks to a significant reduction of patient adverse reactions and pathogen transmissions.
Macopharma develops and manufactures leukoreduction systems to improve the quality and the safety of blood components, allowing better patient outcome.

Giving you the flexibility to fit your processing conditions to better meet your needs

Leucoflex LCRD enables the filtration of a unit of red cells concentrate from buffy coat method and provides a fast filtration process within 20 minutes

Leucoflex LCRD2 enables the filtration of a unit of red cells concentrate from buffy coat method and
offers extended processing conditions up to 72 hours after collection and enables the filtration of
a unit of red cells concentrate from PRP method

LQT system for plasma, buffy coat and leucoreduced Red Blood Cells concentrate preparation

Benefits

High leukoreduction performance
Leucoflex LCRD and LCRD2 provide very high performance far below the European requirement of < 1 x 106 WBC/unit

Compliance with all the European guidelines parameters for red blood cells concentrate

High blood component recovery > 90%

Quality

Leucoflex LCRD and LCRD2 filters are used in more than 30 countries worldwide.
Macopharma is a major global player in the filtration of blood components, with unique
know-how and expertise. We have a deep understanding of your requirements and strive
to provide you with reliable and robust filters, guaranteeing high performance
stability and reproducibility.

Features

Soft housing filter for easy & secure handling

Design allowing visual monitoring during filtration

Fast filtration process

Other products in Leukoreduction
LEUCOFLEX In-line Whole blood leukoreduction filters
Menu